Key statistics
Market cap
BDT 7,078.73 mn
Free float market cap
BDT 2,173.60 mn
NAV per share
BDT 45.29
P/E (audited)
14.52x
Day's value
BDT 12.1 mn
Day's volume
184,082
Day's trades
605
Opening price
BDT 67.00
Adjusted Opening Price
BDT 66.90
Last Update
02:08:20 PM
Day's range
Current BDT 65.90
BDT 65.50BDT 67.00
52-week range
Current BDT 65.90
BDT 45.50BDT 78.00
Basics
- Listing year
- 2022
- Authorized Capital (mn)
- BDT 2,000
- Paid-up capital
- BDT 1,074.16 mn
- Face value
- BDT 10.00
- Total outstanding securities
- 107,416,217
- Market Lot
- 1
Shareholding pattern
as on Jun 28, 2025 (year ended)
as on Jun 30, 2026
as on Jul 31, 2026
Sponsor / Director
31.64%
31.64%
31.64%
Government
0.00%
0.00%
0.00%
Institution
9.42%
10.91%
11.02%
Foreign
19.63%
19.63%
19.63%
Public
39.31%
37.82%
37.71%
Shareholding percentages as reported by the listed company.
Sponsor/Director holdings reflect regulation 2(1)(r) of the DSE (Listing) Regulations 2015.
Corporate & contact
- Present Operational Status
- Active
- Head Office / Registered Office
- 99 Gulshan Avenue, Rupayan Golden Age, 6th Floor, Plot-6, Block-CWN(C), Dhaka-1212
- Factory Address
- 1071, 1073, North Rupshi, Tarabo Municipality, Rupganj, Narayanganj.
- Contact Phone
- 880-2-55033580-3
- Fax
- 880-2-55033579
- cs@navanapharma.com
- Company Secretary Name
- Lorens Shamol Mollick FCS
- Company Secretary Cell No.
- 01321 131222
- Company Secretary Telephone No.
- 02-55033580-3
- Company Secretary E-mail
- secretary@navanapharma.com
- Website
- www.navanapharma.com
- Loan status
- Short-term: BDT 51,823,804 mn · Long-term: BDT 11,016,476 mn
- Present Loan Status — as on
- —
- Credit rating
- Short-term: — · Long-term: —
- Last AGM
- 31-12-2025
- Year-end
- June
Details of Financial Statementhttps://navanapharma.com/page/audited-accounts
Price Sensitive Informationhttps://navanapharma.com/page/psi